KEYS vs ORGO · P/E 57, rev $4.98B vs rev $482.0M
Keysight Technologies Inc (KEYS) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported ORGO revenue for 2024-12-31 was $482.0M. Net income was $861.0K. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. ORGO currently screens at market cap $301.1M.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the KEYS and ORGO stock pages for the full models.
Not investment advice.